sitagliptin/atorvastatin (MK-0431E)
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 20, 2011
A study of the co-administration of sitagliptin and atorvastatin in inadequately controlled type 2 diabetes mellitus (MK-0431E-211)
(clinicaltrials.gov)
- P3, N=750; Not yet recruiting; New P3 trial
New trial • Diabetes
November 13, 2012
Merck & Co stops development of Januvia, atorvastatin combo
(PMLive)
- Merck discontinued development of MK-0431E (sitagliptin and atorvastatin) which had been scheduled for regulatory filings in 2014
Discontinued • Diabetes
1 to 2
Of
2
Go to page
1